BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 27553380)

  • 1. The predictive value of selected serum microRNAs for acute GVHD by TaqMan MicroRNA arrays.
    Zhang C; Bai N; Huang W; Zhang P; Luo Y; Men S; Wen T; Tong H; Wang S; Tian YP
    Ann Hematol; 2016 Oct; 95(11):1833-43. PubMed ID: 27553380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma microRNA signature as a noninvasive biomarker for acute graft-versus-host disease.
    Xiao B; Wang Y; Li W; Baker M; Guo J; Corbet K; Tsalik EL; Li QJ; Palmer SM; Woods CW; Li Z; Chao NJ; He YW
    Blood; 2013 Nov; 122(19):3365-75. PubMed ID: 24041574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomal miRNA Signatures for Late-Onset Acute Graft-Versus-Host Disease in Allogenic Hematopoietic Stem Cell Transplantation.
    Yoshizawa S; Umezu T; Saitoh Y; Gotoh M; Akahane D; Kobayashi C; Ohyashiki JH; Ohyashiki K
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30142940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-153-3p, a new bio-target, is involved in the pathogenesis of acute graft-versus-host disease via inhibition of indoleamine- 2,3-dioxygenase.
    Zhao XS; Wang YN; Lv M; Kong Y; Luo HX; Ye XY; Wu Q; Zhao TF; Hu YH; Zhang HY; Huo MR; Wan J; Huang XJ
    Oncotarget; 2016 Jul; 7(30):48321-48334. PubMed ID: 27340781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma microRNA-586 is a new biomarker for acute graft-versus-host disease.
    Wang Y; Zhao X; Ye X; Luo H; Zhao T; Diao Y; Zhang H; Lv M; Zhang W; Huang X; Wan J
    Ann Hematol; 2015 Sep; 94(9):1505-14. PubMed ID: 26051902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating miRNA panel for prediction of acute graft-versus-host disease in lymphoma patients undergoing matched unrelated hematopoietic stem cell transplantation.
    Gimondi S; Dugo M; Vendramin A; Bermema A; Biancon G; Cavané A; Corradini P; Carniti C
    Exp Hematol; 2016 Jul; 44(7):624-634.e1. PubMed ID: 27013207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum microRNA155 is increased in patients with acute graft-versus-host disease.
    Xie LN; Zhou F; Liu XM; Fang Y; Yu Z; Song NX; Kong FS
    Clin Transplant; 2014 Mar; 28(3):314-23. PubMed ID: 24494749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating miR-455-3p, miR-5787, and miR-548a-3p as potential noninvasive biomarkers in the diagnosis of acute graft-versus-host disease: a validation study.
    Motaei J; Kerachian MA; Mousavi SA; Alimoghadam K; Ghavamzadeh A; Manoochehrabadi S; Ahmadvand M; Yaghmaie M
    Ann Hematol; 2021 Oct; 100(10):2621-2631. PubMed ID: 34247256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum microRNA181a: Correlates with the intracellular cytokine levels and a potential biomarker for acute graft-versus-host disease.
    Xie L; Zhou F; Liu X; Fang Y; Yu Z; Song N; Kong F
    Cytokine; 2016 Sep; 85():37-44. PubMed ID: 27288630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential MicroRNA Expression Levels in Cutaneous Acute Graft-Versus-Host Disease.
    Atarod S; Norden J; Bibby LA; Janin A; Ratajczak P; Lendrem C; Pearce KF; Wang XN; O'Reilly S; Van Laar JM; Collin M; Dickinson AM; Crossland RE
    Front Immunol; 2018; 9():1485. PubMed ID: 30042760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation between Plasma microRNA Expression and Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation].
    Hu B; Fu W; Huang SY; Gao XT; Li DH; Yan XQ; Zhang YP; Liu Q; Liu L; Liang YM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):827-32. PubMed ID: 27342518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Composite biomarker panel for prediction of severity and diagnosis of acute GVHD with T-cell-depleted allogeneic stem cell transplants-single centre pilot study.
    Min SS; Mehra V; Clay J; Cross GF; Douiri A; Dew T; Basu TN; Potter V; Ceesay MM; Pagliuca A; Sherwood RA; Vincent RP
    J Clin Pathol; 2017 Oct; 70(10):886-890. PubMed ID: 28450387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy.
    Fang L; Ellims AH; Moore XL; White DA; Taylor AJ; Chin-Dusting J; Dart AM
    J Transl Med; 2015 Sep; 13():314. PubMed ID: 26404540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA 628-5p as a Novel Biomarker for Cardiac Allograft Vasculopathy.
    Neumann A; Napp LC; Kleeberger JA; Benecke N; Pfanne A; Haverich A; Thum T; Bara C
    Transplantation; 2017 Jan; 101(1):e26-e33. PubMed ID: 27653298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial microparticles delivering microRNA-155 into T lymphocytes are involved in the initiation of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
    Zhang R; Wang X; Hong M; Luo T; Zhao M; Shen H; Fang J; Li X; Zang S; Chen P; Nie D; Zheng P; Wu Q; Xia L
    Oncotarget; 2017 Apr; 8(14):23360-23375. PubMed ID: 28423578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of acute GVHD and relapse by metabolic biomarkers after allogeneic hematopoietic stem cell transplantation.
    Wu X; Xie Y; Wang C; Han Y; Bao X; Ma S; Yilmaz A; Yang B; Ji Y; Xu J; Liu H; Chen S; Zhang J; Yu J; Wu D
    JCI Insight; 2018 May; 3(9):. PubMed ID: 29720575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A preliminary study on clinical diagnostic value of plasma elafin in skin acute graft-versus-host disease].
    Luo CW; Weng JY; Wu SJ; Lu ZS; Guo R; Du X
    Zhonghua Xue Ye Xue Za Zhi; 2012 Nov; 33(11):922-5. PubMed ID: 23363749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation of the level of Reg3α protein in plasma with gastrointestinal acute graft-versus-host disease].
    Cai CS; Chen GH; Sun AN; Qiao M; Liu HW; Chen F; Wang Y; Qiu HY; Han Y; Ma X; Tang XW; Jin ZM; Fu CC; Wu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):785-90. PubMed ID: 24989295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiling Tissue and Biofluid miR-155-5p, miR-155
    Crossland RE; Norden J; Ghimire S; Juric MK; Pearce KF; Lendrem C; Collin M; Mischak-Weissinger E; Holler E; Greinix HT; Dickinson AM
    Front Immunol; 2021; 12():639171. PubMed ID: 33790910
    [No Abstract]   [Full Text] [Related]  

  • 20. MicroRNA-181a, a potential diagnosis marker, alleviates acute graft versus host disease by regulating IFN-γ production.
    Sang W; Zhang C; Zhang D; Wang Y; Sun C; Niu M; Sun X; Zhou C; Zeng L; Pan B; Chen W; Yan D; Zhu F; Wu Q; Cao J; Zhao K; Chen C; Li Z; Li D; Loughran TP; Xu K
    Am J Hematol; 2015 Nov; 90(11):998-1007. PubMed ID: 26223969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.